menu
    • menu
    [{"orgOrder":0,"company":"Praxair Distribution","sponsor":"Praxair Distribution","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Miscellaneous","year":"2019","type":"Inapplicable","leadProduct":"Nitrous Oxide","moa":"N-methyl-D-aspartate receptor (NMDAR)","graph1":"Undisclosed","graph2":"Phase II\/ Phase III","graph3":"Praxair Distribution","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Gas for Inhalation","sponsorNew":"Praxair Distribution \/ Praxair Distribution","highestDevelopmentStatusID":"9","companyTruncated":"Praxair Distribution \/ Praxair Distribution"}]

    Find Clinical Drug Pipeline Developments & Deals by Praxair Distribution

    Menu

    Praxair Distribution

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Praxair Distribution

                            U.S.A arrow
                            OTS 2025
                            Not Confirmed

                            Praxair Distribution

                            U.S.A arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Nitrous Oxide

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase II/ Phase III

                            Recipient : Boston Children's Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Nitrous Oxide for Pain Management During IUD Insertion in Nulliparous Adolescent Women

                            Details : Nitrous Oxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Long-Acting Reversible Contraception.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            September 13, 2019

                            Lead Product(s) : Nitrous Oxide

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase II/ Phase III

                            Recipient : Boston Children's Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth